Target groups: researchers, students, bureaucrats, businesspeople, investors and politicians.
Pictures and videos of each talk
Swipe on the arrows on the pictures in the image carousel below. Links to videos in the caption for each picture.
Programme
Session 1: Welcome and the importance of AI and Horizon Europe for life sciences in the next decade
Welcome: Visions for life science research, education and innovation at UiO and the importance of the new life science building that is ready for use in 2024
Svein Stølen, PhD
Rector, UiO
Chair
Hanne Østli Jakobsen, journalist
Opening speech: Value creation through digitalisation and AI in life sciences – how to utilise Norwegian advantages
Paul Chaffey, State Secretary to the Minister of Regional Development and Digitalisation (Conservative Party)
How to use AI to improve patient care and accelerating medical research
Rabia Khan, PhD MBA
Chief of Translational Medicine, Sensyne Health, UK
Faster and safer cancer prognostics with AI
Håvard E. Danielsen, PhD
Professor, Department of Informatics, UiO; Director, Institute for Cancer Genetics and Informatics, Oslo University Hospital; and PI in the DoMore! project
Improving AI with cutting edge brain research – an interdisciplinary approach
Marianne Fyhn, PhD
Professor, Department of Biosciences, UiO; leader of Centre for Integrative Neuroplasticity (CINPLA); and member of the UiO:Life Science convergence environment MultiModal Mental Models (4MENT)
The ERC in EU Framework Programmes: bringing value from bottom-up research in life sciences
Philippe Cupers, PhD
Head of the Life Sciences unit (ERCEA.B.3), European Research Council (ERC) Executive Agency
View session 1
Session 2: Value creation in life sciences and collaboration across disciplines and sectors in the next decade
New opportunities for collaboration between big pharma and academia in White City Campus in London – a role model for Oslo Science City?
Mark Toms, Dr.
Medical Director & Chief Scientific Officer, Novartis UK
The need for innovation in health care – success stories and success factors and opportunities at BII also for Oslo-based researchers and entrepreneurs
Hervør Lykke Olsen, PhD
Senior business developer, BioInnovation Institute (BII), Denmark
New trends in innovation and collaboration in health-related and environmental life sciences – why are Nordic actors attractive partners for Fraunhofer?
Claus-Dieter Kroggel, PhD
Head of Central Office, Fraunhofer Group for Life Sciences, Germany
Pitches from UiO:Life Science's convergence environments, projects in UiO:Life Science's innovation programme for health related life sciences SPARK Norway and industry in Oslo
Moderator pitching session
Jutta Heix, Oslo Cancer Cluster
Future models for diabetes research by using new strategies for stem cell differentiation – collaboration between medicine, musicology and physics
Hanne Scholz, PhD
Leader of the convergence environment Artificial Biomimetic systems – the Niche of Islet Organoids (ABINO), PI in the convergence environment Organ on a chip and Vice Director of the Centre of Excellence Hybrid Technology Hub
Inhibition of aortic valve calcification
SPARKee Kåre-Olav Stensløkken, Professor
Institute of Basic Medical Sciences, Faculty of Medicine, UiO. He is also leader a convergence environment.
MyFood – a decision support system to prevent and treat disease-related malnutrition
SPARKee Mari Mohn Paulsen, PhD student
Department of Nutrition, Institute of Basic Medical Sciences, Faculty of Medicine, UiO
Fabuli – Faster and Better Ultrasound Imaging
SPARKee Andreas Austeng, Professor
Department of Informatics, The Faculty of Mathematics and Natural Sciences, UiO
Empowering cancer immunotherapy with AI
Jenny-Ann Malmberg, PhD
Software Development Manager, NEC Oncoimmunity
Legal aspects of AI
Vibeke Binz Vallevik
Project Manager the BIGMED Project, DNV GL Precision Medicine research and OUS Intervention Center
View session 2
Session 3: The future of Oslo as a life science hub
Conversation between Carl Henrik Gørbitz, director of UiO:Life Science, and the new UiO:Life Science Strategic Advisory Board (SAB). We will get their interdisciplinary perspectives on what they have heard throughout the event and how they see Oslo as a hub for life science-related activities in the years to come. Members of the SAB:
- Sirpa Jalkanen, Professor of Immunology, Academician, Director of MediCity, University of Turku, Finland
- Jari Koistinaho, Director of Neuroscience Center, Helsinki Institute of Life Science, University of Helsinki and Professor of Regenerative Medicine, University of Eastern Finland
- Melissa Parker, Professor of Medical Anthropology, Department of Global Health and Development, London School of Hygiene and Tropical Medicine
- Laurence D. Hurst, Professor of Evolutionary Genetics and Director of the Milner Centre for Evolution Department of Biology and Biochemistry, The University of Bath
18.30 End of event in the aula
19.00 Reception hosted by the City of Oslo in Oslo City Hall
Reception hosted by the City of Oslo in Oslo City Hall after the main event.
The reception is fully booked, but you may sign up for the waiting list for the reception when you sign up for the main event.
